eMedicine Specialties > Radiology > Head/Neck

Glomus Tumor (Head and Neck): Imaging

Author: Robert A Koenigsberg, DO, MSc, FAOCR, Director of Neuroradiology, Professor, Department of Radiology, Drexel University College of Medicine
Coauthor(s): Cyrus Dastur, BS, Department of Neuroradiology, MCP Hahnemann University; Robert Kim, BS, Department of Neuroradiology, Hahnemann University Hospital
Contributor Information and Disclosures

Updated: Jan 29, 2008

Radiography

Findings

Routine plain-film radiography does not have a role in the diagnosis of glomus tumors.

Computed Tomography

Findings

Contrast-enhanced CT demonstrates enhancing soft-tissue masses at characteristic locations key to diagnosis. Nonenhanced CT imaging can demonstrate glomus tumors, but the demonstration of a strongly enhancing mass is typical in the diagnosis of a glomus tumor.13,19

CT demonstrates carotid body tumors at the level of the carotid bifurcation, respectively splaying the internal and external carotid arteries medially and laterally. These tumors can vary in size, but their location within the bifurcation is critical for diagnosis.

Glomus vagale tumors are masses with similarly strong enhancement. These tumors are seen along the course of the jugular vein and internal carotid artery above the level of the carotid bifurcation but below the skull base. These tumors can vary in size, and they can displace adjacent vascular structures.

Glomus jugulare tumors are enhancing soft-tissue masses at the skull base, but skull-base artifact can mask their presence. These tumors are seen within the jugular foramen; the demonstration of bone erosion of the jugular foramen and petrous apex is often a key finding in the diagnosis. Careful review of bone windows is necessary.

Degree of Confidence

The degree of confidence is high. The presence of strongly enhancing neck masses in typical perivascular locations lead to a high degree of confidence regarding diagnosis.

False Positives/Negatives

Hypervascular lymphadenopathy may result in false-positive findings, which can be seen in a variety of disorders such as metastatic papillary carcinoma of the thyroid gland. In these instances, the location is a key finding.

The lack of sufficient contrast enhancement can be troublesome and may result in false-negative findings. In this case, glomus tumors can mimic schwannomas, neurofibromas, or nonenhancing lymphadenopathies. Potentially, small vascular tumors can be missed if they are not easily distinguishable from the adjacent vascular structures.

Magnetic Resonance Imaging

Findings

Similar to CT imaging, contrast-enhanced MRI demonstrates enhancing soft-tissue masses at characteristic locations; these findings are important for diagnosis. Nonenhanced MRI can demonstrate glomus tumors, but the demonstration of a strongly enhancing mass is typical in the diagnosis of a glomus tumor.19,20,21

As with most soft-tissue tumors, glomus tumors are isointense on T1-weighted MRIs and hyperintense on T2-weighted MRIs, relative to skeletal muscle.

Contrast-enhanced imaging can show intense tumor enhancement, which again is a key finding in the diagnosis. In addition, a salt-and-pepper fine vascular pattern can be seen in the tumors; this finding is suggestive of intrinsic tumor neovascularity and is particularly well demonstrated on T2-weighted images.

MRIs can show densely enhancing carotid body tumors at the level of the carotid bifurcation, which respectively splay the internal and external carotid arteries medially and laterally.

Glomus jugulare tumors are particularly well demonstrated by using MRI. Images show that enhancing soft-tissue masses protrude both intracranially and extracranially at the skull base.

Direct coronal imaging can show tumoral relationships to adjacent structures such as the brainstem and skull base, and deep cervical soft-tissue structures are extraordinarily well depicted.

Degree of Confidence

The degree of confidence is high. Tumor allocation and intense tumor enhancement are of paramount importance in diagnosis.

False Positives/Negatives

Hypervascular lymphadenopathy may result in false-positive findings, which can be seen in a variety of disorders such as metastatic papillary carcinoma of the thyroid gland. In particular, MRI findings can be confusing if T2-weighted images show a salt-and-pepper pattern. In such instances, the location is a key finding.

As with CT imaging, the lack of sufficient contrast enhancement can be troublesome and may result in false-negative findings. In this case, glomus tumors can mimic schwannomas, neurofibromas, or nonenhancing lymphadenopathies if an insufficient amount of contrast material is administered. Potentially, small vascular tumors can be missed if they are not clearly distinguishable from the adjacent vascular structures.

Ultrasonography

Findings

Doppler ultrasonography (US) can demonstrate cervical masses when they are imaged below the angle of the mandible, above the sternum, or in a superficial location not hidden by bone. US can demonstrate the extent of the masses and show their locations. In glomus tumors, the diagnosis of carotid body tumors is possible with US cervical imaging, but US does not suitably reveal the location of glomus vagale, jugulare, and tympanicum tumors.

Because of tumor neovascularity, Doppler US sampling of cervical masses, such as carotid body tumors, can be helpful in diagnosis. In addition, if recognized, increased flow velocities in the external carotid artery or in the jugular vein can provide an indirect clue to the diagnosis of a vascular mass that is above the US imaging field.

Degree of Confidence

The degree of confidence is high if these tumors are found by using US.

False Positives/Negatives

Hypervascular lymphadenopathy can mimic a glomus tumor and cause a false-positive result.

Many glomus tumors are seen in the neck above the level of the mandibular angle, rendering the diagnosis impossible by using US alone; a false-negative finding can result.

Angiography

Findings

Glomus tumors of the head and neck are typically highly vascular, as shown on angiograms. This finding differentiates them from other types of neck neoplasia.

Typical carotid body tumors are situated in the carotid bifurcation and derive their arterial supply from regional external carotid branch arteries. These include the ascending pharyngeal and occipital arteries.

Glomus vagale and jugulare tumors are encountered higher in the neck and at the skull base; therefore, these masses concomitantly involve higher external carotid branch vessels; the ascending pharyngeal, tympanic, and occipital arteries dominate the arterial blood supply. The neovascularity may be extremely intense, and arteriovenous fistulae may be present. Rarely, the internal carotid and vertebral arteries may contribute feeders to the neoplasms. Typically, these tumors are evaluated, with attention paid to all potential feeding arteries. Care is taken to evaluate occult contralateral or ipsilateral masses, which can be occasionally overlooked during cross-sectional imaging.

Degree of Confidence

Degree of confidence is high. The hallmark of a glomus tumor is its intrinsic neovascularity.

False Positives/Negatives

At times, lymph node neovascularity can be difficult to differentiate from glomus tumors. In these situations, the location is a key feature.

More on Glomus Tumor (Head and Neck)

Overview: Glomus Tumor (Head and Neck)
Imaging: Glomus Tumor (Head and Neck)
Follow-up: Glomus Tumor (Head and Neck)
Multimedia: Glomus Tumor (Head and Neck)
References

References

  1. Glenner GG, Grimley PM. Tumors of the extra-adrenal paraganglion system (including chemoreceptors). In: Atlas of Tumor Pathology, Second Series. Armed Forces Institute of Pathology;1974.

  2. Marlowe SD, Swartz JD, Koenigsberg R, et al. Metastatic hypernephroma to the larynx: an unusual presentation. Neuroradiology. 1993;35(3):242-3. [Medline].

  3. Mafee MF, Raofi B, Kumar A, Muscato C. Glomus faciale, glomus jugulare, glomus tympanicum, glomus vagale, carotid body tumors, and simulating lesions. Role of MR imaging. Radiol Clin North Am. Sep 2000;38(5):1059-76. [Medline].

  4. Patel SJ, Sekhar LN, Cass SP, Hirsch BE. Combined approaches for resection of extensive glomus jugulare tumors. A review of 12 cases. J Neurosurg. Jun 1994;80(6):1026-38. [Medline].

  5. Pluta RM, Ram Z, Patronas NJ, Keiser H. Long-term effects of radiation therapy for a catecholamine-producing glomus jugulare tumor. Case report. J Neurosurg. Jun 1994;80(6):1091-4. [Medline].

  6. Li G, Chang S, Adler JR Jr, Lim M. Irradiation of glomus jugulare tumors: a historical perspective. Neurosurg Focus. 2007;23(6):E13. [Medline].

  7. Henzel M, Hamm K, Gross MW, Surber G, Kleinert G, Failing T. Fractionated stereotactic radiotherapy of glomus jugulare tumors. Local control, toxicity, symptomatology, and quality of life. Strahlenther Onkol. Oct 2007;183(10):557-62. [Medline].

  8. Varma A, Nathoo N, Neyman G, Suh JH, Ross J, Park J. Gamma knife radiosurgery for glomus jugulare tumors: volumetric analysis in 17 patients. Neurosurgery. Nov 2006;59(5):1030-6; discussion 1036. [Medline].

  9. Pemberton LS, Swindell R, Sykes AJ. Radical radiotherapy alone for glomus jugulare and tympanicum tumours. Oncol Rep. Dec 2005;14(6):1631-3. [Medline].

  10. Cheng A, Niparko JK. Imaging quiz case 2. Glomus tympanicum tumor of the temporal bone. Arch Otolaryngol Head Neck Surg. May 1997;123(5):549, 551-2. [Medline].

  11. O''Leary MJ, Shelton C, Giddings NA, et al. Glomus tympanicum tumors: a clinical perspective. Laryngoscope. Oct 1991;101(10):1038-43. [Medline].

  12. Salami A, Mora R, Dellepiane M. Piezosurgery in the exeresis of glomus tympanicum tumours. Eur Arch Otorhinolaryngol. Jan 4 2008;[Medline].

  13. Coulier B, Mailleux P, Lefrancq M. Images in clinical radiology. Glomus tympanicum: CT diagnosis. JBR-BTR. Nov-Dec 2003;86(6):359. [Medline].

  14. Biller HF, Lawson W, Som P, Rosenfeld R. Glomus vagale tumors. Ann Otol Rhinol Laryngol. Jan 1989;98(1 Pt 1):21-6. [Medline].

  15. Cheng AG, Maronian NC, Futran ND. Cerebrospinal fluid leak in the neck: a rare complication of glomus vagale excision. Otolaryngol Head Neck Surg. Feb 2006;134(2):334-5. [Medline].

  16. Karatas E, Sirikci A, Baglam T, Mumbuc S, Durucu C, Tutar E. Synchronous bilateral carotid body tumor and vagal paraganglioma: A case report and review of literature. Auris Nasus Larynx. Mar 2008;35(1):171-5. [Medline].

  17. Piazza P, Di Lella F, Menozzi R, Bacciu A, Sanna M. Absence of the contralateral internal carotid artery: a challenge for management of ipsilateral glomus jugulare and glomus vagale tumors. Laryngoscope. Aug 2007;117(8):1333-7. [Medline].

  18. Smith JJ, Passman MA, Dattilo JB, Guzman RJ, Naslund TC, Netterville JL. Carotid body tumor resection: does the need for vascular reconstruction worsen outcome?. Ann Vasc Surg. Jul 2006;20(4):435-9. [Medline].

  19. Som PM, Curtin HD. Head and Neck Imaging. 3rd ed. Mosby-Year Book;1996:932-6, 1484-96.

  20. Vogl TJ, Juergens M, Balzer JO, et al. Glomus tumors of the skull base: combined use of MR angiography and spin-echo imaging. Radiology. Jul 1994;192(1):103-10. [Medline].

  21. van den Berg R, van Gils AP, Wasser MN. Imaging of head and neck paragangliomas with three-dimensional time-of- flight MR angiography. AJR Am J Roentgenol. Jun 1999;172(6):1667-73. [Medline].

  22. Jackson CG. Neurotologic skull base surgery for glomus tumors. Diagnosis for treatment planning and treatment options. Laryngoscope. Nov 1993;103(11 Pt 2 Suppl 60):17-22. [Medline].

  23. Woods CI, Strasnick B, Jackson CG. Surgery for glomus tumors: the Otology Group experience. Laryngoscope. Nov 1993;103(11 pt 2 suppl 60):65-70. [Medline].

  24. van der Mey AG, Frijns JH, Cornelisse CJ, et al. Does intervention improve the natural course of glomus tumors? A series of 108 patients seen in a 32-year period. Ann Otol Rhinol Laryngol. Aug 1992;101(8):635-42. [Medline].

Further Reading

Keywords

chemodectoma, nonchromaffin paraganglioma, glomus body tumors, paraganglioma, glomus jugulare tumors, glomus tympanicum tumors, glomus vagale tumors, carotid body glomus tumors, carotid body tumors

Contributor Information and Disclosures

Author

Robert A Koenigsberg, DO, MSc, FAOCR, Director of Neuroradiology, Professor, Department of Radiology, Drexel University College of Medicine
Robert A Koenigsberg, DO, MSc, FAOCR is a member of the following medical societies: American Osteopathic Association, American Society of Interventional & Therapeutic Neuroradiology, American Society of Neuroradiology, and Radiological Society of North America
Disclosure: Nothing to disclose.

Coauthor(s)

Cyrus Dastur, BS, Department of Neuroradiology, MCP Hahnemann University
Cyrus Dastur, BS is a member of the following medical societies: American Medical Student Association/Foundation
Disclosure: Nothing to disclose.

Robert Kim, BS, Department of Neuroradiology, Hahnemann University Hospital
Disclosure: Nothing to disclose.

Medical Editor

Barton F Branstetter IV, MD, Assistant Professor of Radiology and Otolaryngology, University of Pittsburgh; Director of Head and Neck Imaging, Associate Director of Informatics, Department of Radiology, Division of Neuroradiology, University of Pittsburgh Medical Center
Barton F Branstetter IV, MD is a member of the following medical societies: American College of Radiology, American Medical Association, American Roentgen Ray Society, American Society of Neuroradiology, Pennsylvania Medical Society, and Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Bernard D Coombs, MB, ChB, PhD, Consulting Staff, Department of Specialist Rehabilitation Services, Hutt Valley District Health Board, New Zealand
Disclosure: Nothing to disclose.

Managing Editor

C Douglas Phillips, MD, Professor, Departments of Radiology, Neurosurgery, and Otolaryngology, University of Virginia Health Sciences Center
C Douglas Phillips, MD is a member of the following medical societies: American College of Radiology, American Medical Association, American Society of Head and Neck Radiology, American Society of Neuroradiology, Association of University Radiologists, and Radiological Society of North America
Disclosure: Nothing to disclose.

CME Editor

Robert M Krasny, MD, Consulting Staff, Department of Radiology, The Angeles Clinic and Research Institute
Robert M Krasny, MD is a member of the following medical societies: American Roentgen Ray Society and Radiological Society of North America
Disclosure: Nothing to disclose.

Chief Editor

Lawrence M Davis, MD, Assistant Professor of Diagnostic Imaging (Clinical), Department of Diagnostic Imaging, Brown Medical School
Lawrence M Davis, MD is a member of the following medical societies: American College of Radiology, American Roentgen Ray Society, American Society of Neuroradiology, Radiological Society of North America, and Rhode Island Medical Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.